Freshfields advises Haleon on $3.1 billion secondary global offering and $400 million share buyback from Pfizer

The Sponsor

Loading page...

Freshfields advises Haleon on $3.1 billion secondary global offering and $400 million share buyback from Pfizer | The Sponsor - The Sponsor